The Trump administration has let go of two key leaders from major health organizations that determine when preventive healthcare services, like mammograms and colonoscopies, should be offered free to millions of Americans.
In a letter dated May 11, Secretary of Health Robert F. Kennedy Jr. notified the two physicians who were chairs of the U.S. Preventive Services Task Force that their appointments would be cut short, effective immediately. This was unexpected, given that their multi-year terms had not yet finished.
The Department of Health and Human Services has missed a number of task force meetings and has delayed public meetings that were slated for the past year. This has put crucial updates on cervical cancer screening and other significant topics in a state of uncertainty.
The committee, established in the 1980s, consists of experts who evaluate the latest research on various disease prevention strategies, such as screening for depression and the use of statins to avert heart attacks. The group is also set to update their guidelines to include letter grades for indicating the strength of scientific conclusions. According to the Affordable Care Act, most insurance plans need to cover preventive services rated “A” or “B” at no out-of-pocket cost for patients.
Kennedy’s letter did not specify why the two doctors, John Wong and Ether Davis, were dismissed. He did, however, encourage them to reapply, commending their “leadership, contributions, and expertise,” which he believes have benefited the task force’s mission to enhance public health. Kennedy indicated he was reviewing the task force’s appointments for “clarity, continuity, and credibility” within HHS oversight.
The letter, first disclosed by the New York Times, saw no reply from a Ministry of Health spokesperson regarding the dismissals.
Last month, President Kennedy criticized the task force as “lazy” and mentioned reforming it to ensure more frequent meetings and greater transparency. As part of these reforms, the committee intends to hold public meetings where citizens can weigh in on draft guidelines and the scientific evidence supporting them before final adoption.
Some health advocates expressed concern that Kennedy’s administration might be inclined to replace panels of experts with less experienced political appointees, mirroring changes made with his vaccine advisory committee. Over the last year, the task force has been prevented from finalizing updates for cervical cancer screening recommendations or revising guidelines regarding maternal depression, as noted by former chair and pediatrician Dr. Michael Silverstein.
“This is a level of government interference in the scientific process that I have not experienced in the 10 years I have been on the task force,” he stated.
Aaron Carroll from the nonpartisan health policy group Academy Health mentioned that the task force usually has staggered terms. This system helps ensure that the secretary of health can appoint new members regularly while maintaining stability within the committee.
